Hsieh Ming

Chief Executive Officer, Director, 10% OwnerFulgent Genetics, Inc. (FLGT) · full profile →Form 4 · filed Feb 25, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2026Grant(A)69K$0921K
Feb 24, 2026Grant(A)19K$0816K
Feb 24, 2026Grant(A)40K$0856K
Feb 24, 2026Grant(A)59K$0915K
Feb 24, 2026Tax withholding(F)10K$23.09$236K905K
Feb 24, 2026Tax withholding(F)21K$23.09$493K884K
Feb 24, 2026Tax withholding(F)32K$23.09$733K852K
Feb 23, 2026Tax withholding(F)2K$23.01$50K797K

Transaction Codes

A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-072637) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about FLGT insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193125-26-072637"
Ask your agent
Use Arkolith to summarize insider buying and selling at Fulgent Genetics, Inc.
over the last 90 days and cite the filings.